Jonathan D Grinstein is a Senior Editor at Genetic Engineering & Biotechnology News. With a background in Neural Science and Philosophy, as well as a doctorate in Biomedical, he combines his expertise in experimental and computational research with a passion for science writing. Jonathan's work has been featured in prominent publications such as Scientific American and NEO.LIFE.
Preston's Summary
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Geo Focus
United States (National)
Coverage Attributes:
Beta
Cites Data:
43
%
Press Release:
21
%
Industry Specific:
17
%
Private Sector Announcements:
13
%
Expert Commentary:
4
%
Themes Covered:
Not enough data
Most Recent Topics:
Not enough data
Pitching Insights
Jonathan D Grinstein's coverage primarily focuses on the healthcare and pharmaceutical industries, with an emphasis on scientific advancements such as biotechnology, drug development, gene therapy, AI in healthcare, and mRNA vaccines. His articles often include industry-specific details and data citations.
Given this focus, Jonathan is likely to be interested in receiving pitches from experts who can provide insights into recent scientific breakthroughs or developments within the mentioned topics. Academics conducting cutting-edge research or professionals involved in innovative projects could offer valuable perspectives for his articles.
It appears that Jonathan does not have a specific geographic focus but instead covers global advancements within the healthcare and pharmaceutical sectors. Therefore, sources with international expertise would likely appeal to him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
